Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.


The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page


My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1868 1
1956 2
1969 1
1973 1
1975 4
1977 4
1978 2
1979 4
1980 6
1981 5
1982 7
1983 4
1984 6
1985 14
1986 10
1987 11
1988 12
1989 11
1990 9
1991 12
1992 10
1993 9
1994 24
1995 17
1996 13
1997 13
1998 4
1999 18
2000 22
2001 28
2002 23
2003 21
2004 18
2005 27
2006 15
2007 31
2008 14
2009 14
2010 15
2011 11
2012 7
2013 9
2014 9
2015 10
2016 11
2017 14
2018 14
2019 20
2020 16
2021 15
2022 20
2023 31
2024 6

Text availability

Article attribute

Article type

Publication date

Search Results

622 results

Results by year

Filters applied: . Clear all
Page 1
Teclistamab in Relapsed or Refractory Multiple Myeloma.
Moreau P, Garfall AL, van de Donk NWCJ, Nahi H, San-Miguel JF, Oriol A, Nooka AK, Martin T, Rosinol L, Chari A, Karlin L, Benboubker L, Mateos MV, Bahlis N, Popat R, Besemer B, Martínez-López J, Sidana S, Delforge M, Pei L, Trancucci D, Verona R, Girgis S, Lin SXW, Olyslager Y, Jaffe M, Uhlar C, Stephenson T, Van Rampelbergh R, Banerjee A, Goldberg JD, Kobos R, Krishnan A, Usmani SZ. Moreau P, et al. Among authors: stephenson t. N Engl J Med. 2022 Aug 11;387(6):495-505. doi: 10.1056/NEJMoa2203478. Epub 2022 Jun 5. N Engl J Med. 2022. PMID: 35661166 Free PMC article. Clinical Trial.
Teclistamab, a B-cell maturation antigen × CD3 bispecific antibody, in patients with relapsed or refractory multiple myeloma (MajesTEC-1): a multicentre, open-label, single-arm, phase 1 study.
Usmani SZ, Garfall AL, van de Donk NWCJ, Nahi H, San-Miguel JF, Oriol A, Rosinol L, Chari A, Bhutani M, Karlin L, Benboubker L, Pei L, Verona R, Girgis S, Stephenson T, Elsayed Y, Infante J, Goldberg JD, Banerjee A, Mateos MV, Krishnan A. Usmani SZ, et al. Among authors: stephenson t. Lancet. 2021 Aug 21;398(10301):665-674. doi: 10.1016/S0140-6736(21)01338-6. Epub 2021 Aug 10. Lancet. 2021. PMID: 34388396 Clinical Trial.
The prevalence and long-term health effects of Long Covid among hospitalised and non-hospitalised populations: A systematic review and meta-analysis.
O'Mahoney LL, Routen A, Gillies C, Ekezie W, Welford A, Zhang A, Karamchandani U, Simms-Williams N, Cassambai S, Ardavani A, Wilkinson TJ, Hawthorne G, Curtis F, Kingsnorth AP, Almaqhawi A, Ward T, Ayoubkhani D, Banerjee A, Calvert M, Shafran R, Stephenson T, Sterne J, Ward H, Evans RA, Zaccardi F, Wright S, Khunti K. O'Mahoney LL, et al. Among authors: stephenson t. EClinicalMedicine. 2022 Dec 1;55:101762. doi: 10.1016/j.eclinm.2022.101762. eCollection 2023 Jan. EClinicalMedicine. 2022. PMID: 36474804 Free PMC article.
Effects of teclistamab and talquetamab on soluble BCMA levels in patients with relapsed/refractory multiple myeloma.
Girgis S, Wang Lin SX, Pillarisetti K, Verona R, Vieyra D, Casneuf T, Fink D, Miao X, Chen Y, Stephenson T, Banerjee A, Hilder BW, Russell J, Infante J, Elsayed Y, Smit J, Goldberg JD. Girgis S, et al. Among authors: stephenson t. Blood Adv. 2023 Feb 28;7(4):644-648. doi: 10.1182/bloodadvances.2022007625. Blood Adv. 2023. PMID: 36006441 Free PMC article. No abstract available.
Continuously advancing quality care.
Molloy A, Stephenson T, Marshall M. Molloy A, et al. Among authors: stephenson t. Arch Dis Child. 2022 Feb;107(2):107-108. doi: 10.1136/archdischild-2020-321394. Epub 2021 Jan 17. Arch Dis Child. 2022. PMID: 33455905 No abstract available.
Chemical editing of proteoglycan architecture.
O'Leary TR, Critcher M, Stephenson TN, Yang X, Hassan AA, Bartfield NM, Hawkins R, Huang ML. O'Leary TR, et al. Among authors: stephenson tn. Nat Chem Biol. 2022 Jun;18(6):634-642. doi: 10.1038/s41589-022-01023-5. Epub 2022 May 12. Nat Chem Biol. 2022. PMID: 35551261 Free PMC article.
Long COVID in children and adolescents.
Stephenson T, Shafran R, Ladhani SN. Stephenson T, et al. Curr Opin Infect Dis. 2022 Oct 1;35(5):461-467. doi: 10.1097/QCO.0000000000000854. Epub 2022 Aug 3. Curr Opin Infect Dis. 2022. PMID: 36098262 Free PMC article.
Global change influences scavenging and carrion decomposition.
Bartel SL, Stephenson T, Crowder DW, Jones ME, Storfer A, Strickland MS, Lynch L. Bartel SL, et al. Among authors: stephenson t. Trends Ecol Evol. 2024 Feb;39(2):152-164. doi: 10.1016/j.tree.2023.09.008. Epub 2023 Oct 9. Trends Ecol Evol. 2024. PMID: 37816662 Review.
Prevention and Therapeutic Innovation in the Management of Child Health.
Hoey H, Stephenson T, Namazova-Baranova L, Pettoello-Mantovani M, Mestrovic J, Vural M, Crushell E. Hoey H, et al. Among authors: stephenson t. J Pediatr. 2019 May;208:300-301. doi: 10.1016/j.jpeds.2019.01.056. J Pediatr. 2019. PMID: 31027629 No abstract available.
622 results